0.5388
price down icon7.90%   -0.0462
pre-market  Vorhandelsmarkt:  .53   -0.0088   -1.63%
loading

Clearside Biomedical Inc Aktie (CLSD) Neueste Nachrichten

pulisher
02:27 AM

What drives Clearside Biomedical Inc. stock priceFree Real-Time Stock Data - PrintWeekIndia

02:27 AM
pulisher
Jul 24, 2025

Clearside Biomedical Receives Canadian Approval for XIPERE® to Treat Uveitic Macular Edema via Suprachoroidal Delivery - MSN

Jul 24, 2025
pulisher
Jul 24, 2025

Clearside Biomedical Announces Approval of XIPERE® - GlobeNewswire

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Clearside Biomedical Inc. stockPhenomenal wealth increase - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Clearside Biomedical Inc. a good long term investmentExceptional portfolio growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Clearside Biomedical stock soars after Health Canada approves XIPERE - Investing.com Australia

Jul 23, 2025
pulisher
Jul 23, 2025

Clearside Biomedical stock soars after Health Canada approves XIPERE By Investing.com - Investing.com UK

Jul 23, 2025
pulisher
Jul 23, 2025

Health Canada approves Clearside’s XIPERE for uveitic macular edema By Investing.com - Investing.com Nigeria

Jul 23, 2025
pulisher
Jul 23, 2025

Breakthrough Eye Treatment XIPERE Secures Major Health Canada Approval for Macular Edema - Stock Titan

Jul 23, 2025
pulisher
Jul 22, 2025

Clearside Biomedical Inc. Stock Analysis and ForecastFree Market Volatility Navigation Tips - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Clearside Biomedical Inc. stock attracts strong analyst attentionFree Growth Investment Group - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Clearside exploring options to advance suprachoroidal delivery platform - Eyes On Eyecare

Jul 22, 2025
pulisher
Jul 22, 2025

Clearside Biomedical announces plan to explore strategic alternatives to advance its proprietary suprachoroidal space (SCS) delivery platform and promising ophthalmology pipeline - Eyes On Eyecare

Jul 22, 2025
pulisher
Jul 21, 2025

Analysts Set Clearside Biomedical, Inc. (NASDAQ:CLSD) Target Price at $4.20 - Defense World

Jul 21, 2025
pulisher
Jul 21, 2025

Uncovering the Potential of Clearside Biomedical Inc (CLSD) Stock - investchronicle.com

Jul 21, 2025
pulisher
Jul 21, 2025

Clearside Biomedical (NASDAQ:CLSD) Downgraded by Stifel Nicolaus to "Hold" - MarketBeat

Jul 21, 2025
pulisher
Jul 20, 2025

Chardan Capital Downgrades Clearside Biomedical (NASDAQ:CLSD) to Neutral - Defense World

Jul 20, 2025
pulisher
Jul 19, 2025

What institutions are buying Clearside Biomedical Inc. stock nowFree Stock Trading Signals - beatles.ru

Jul 19, 2025
pulisher
Jul 18, 2025

Published on: 2025-07-18 21:44:13 - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Clearside Biomedical downgraded to Neutral from Buy at H.C. Wainwright - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Health Care Stocks Stumble As Sector Faces Fresh Setbacks - Finimize

Jul 18, 2025
pulisher
Jul 18, 2025

Deal Dispatch: Del Taco Tanks, Tylenol Maker Aches For Change, Joyebells Burns The Pie - Benzinga

Jul 18, 2025
pulisher
Jul 18, 2025

Published on: 2025-07-18 22:42:56 - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

This Verint Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga

Jul 18, 2025
pulisher
Jul 18, 2025

A Quick Look at Today's Ratings for Clearside Biomedical(CLSD.US), With a Forecast Between $0.84 to $3 - 富途牛牛

Jul 18, 2025
pulisher
Jul 18, 2025

Clearside Biomedical downgraded to Neutral from Buy at Chardan - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

This Elevance Health Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga

Jul 18, 2025
pulisher
Jul 18, 2025

CLSD: Downgraded to Neutral by HC Wainwright & Co. | CLSD Stock News - GuruFocus

Jul 18, 2025
pulisher
Jul 18, 2025

Why Clearside Biomedical Inc. stock is on top investor watchlistsHigh Return Stock Alerts - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Chardan Capital downgrades Clearside Biomedical stock rating to Neutral By Investing.com - Investing.com Canada

Jul 18, 2025
pulisher
Jul 18, 2025

Chardan Capital downgrades Clearside Biomedical stock rating to Neutral - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

Stifel downgrades Clearside Biomedical stock to Hold on cash concerns By Investing.com - Investing.com Nigeria

Jul 18, 2025
pulisher
Jul 18, 2025

Stifel downgrades Clearside Biomedical stock to Hold on cash concerns - Investing.com Australia

Jul 18, 2025
pulisher
Jul 17, 2025

Clearside Biomedical Downgraded to Hold Amid Strategic and Financial Uncertainties - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Clearside Biomedical downgraded to Hold from Buy at Stifel - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Clearside Biomedical Announces Plan to Explore Strategic - GlobeNewswire

Jul 17, 2025
pulisher
Jul 17, 2025

Alpharetta biomedical company ‘exploring strategic alternatives’ as job cuts loom - The Business Journals

Jul 17, 2025
pulisher
Jul 17, 2025

Clearside Biomedical shares dip after announcing exploration of strategic alternatives - MSN

Jul 17, 2025
pulisher
Jul 17, 2025

Clearside Biomedical to explore strategic alternatives to advance SCS platform - TipRanks

Jul 17, 2025
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Kapitalisierung:     |  Volumen (24h):